News
-
Comprehend Raises $21 Million In Series B Funding
8/19/2014
Comprehend today announced it has secured $21 million in Series B financing to accelerate clinical development through its cloud-based business intelligence solutions, enabling life science companies to bring new treatments and devices to market faster and more affordably. The round was led by Lightspeed Venture Partners with support from existing investor Sequoia Capital. Lightspeed partner Peter Nieh joined the company’s board of directors.
-
Medidata And TransCelerate BioPharma Inc. Announce Joint Initiative
5/20/2014
Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it is partnering with TransCelerate BioPharma Inc. ("TransCelerate") on a project designed to inform the nonprofit organization’s continued efforts to modernize and streamline the way clinical trials are conducted and monitored worldwide.
-
Laurence Burke Joins Exco Intouch As Vice President Of Operations
2/19/2014
Exco InTouch, the leading provider of patient engagement and data capture solutions for clinical research and healthcare providers, recently announced the appointment of Laurence Burke as Vice President of Operations.
-
Bioclinica, Inc. To Demonstrate Technology-Enhanced Capabilities At Upcoming Global Industry Events
4/2/2013
BioClinica, Inc. a global provider of clinical trial management solutions, recently announced that members of its team will attend, participate in, and speak at several upcoming industry conferences in April, May, and June.
-
Exco InTouch Joins Critical Path Institute ePRO Consortium To Advance Electronic Data Capture In Clinical Trials
2/6/2013
Exco InTouch, the leading provider of patient engagement, data collection and communication solutions for the pharmaceutical and healthcare sectors, recently announced that it has joined the Electronic Patient-Reported Outcome (ePRO) Consortium, a programme run by the Critical Path Institute (C-Path), which strives to enhance the quality of patient reported outcomes (PRO) in the evaluation of new pharmaceuticals.
-
Clinovo Announces Successful Attainment Status Of CDISC Registered Solutions
4/26/2012
Clinovo announces that it has successfully attained the status of CDISC Registered Solutions Provider by the Clinical Data Interchange Standards Consortium (CDISC) organization. With this milestone, Clinovo demonstrates its active participation in the pharmaceutical industry in the implementation of clinical standards.
-
CDISC Partners With DIA And IHE To Demonstrate EHRs For Medical Research
6/22/2011
The Clinical Data Interchange Standards Consortium (CDISC) is pleased to announce its collaboration with DIA and Integrating the Healthcare Enterprise (IHE) to bring a state-of-the-art demonstration of the implementation of electronic health records (EHRs) to streamline medical research.